Lyndra Therapeutics
Douglas Dachille is on the Board of Directors of Lyndra Therapeutics. He is also the Chief Executive Officer and Chief Investment Officer at First Principles Capital Management, LLC.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Lyndra Therapeutics
Lyndra Therapeutics is pioneering the first-ever oral, ultra-long-acting, sustained-release therapies, which have the potential to fundamentally change the way people take medicine by enabling patients to take a pill once a week rather than daily.